MedPath

Human Fresh Corneal Lenticule Implantation Criteria in Progressive Corneal Disease Using Relex-Smile

Not Applicable
Conditions
Progressive Disease of Corneae
Interventions
Device: ReLex-smile
Registration Number
NCT04848740
Lead Sponsor
Eye Hospital Pristina Kosovo
Brief Summary

Stroma is a fibrous, tough, transparent and the thickest layer of the corneae. The stroma is composed of organised collagen, which maintains transparency. Keratocytes are located between the lamella collagen fibers and secrete an extracellular matrix, which includes collagen, proteoglycan, crystalline proteins to maintain corneal transparency.

Detailed Description

Knowing the importance of stroma(90%) in function and anatomy of corneae (transparence, curvature, strength, protection) the inner eye structures from external environment, we have examined the role and function of stroma as a main factor of corneal thickness in implanting fresh corneal lenticule in progressive corneal disease.

We have studied that in many clinical cases where the corneal epithelium and endothelium are healthy and functioning, the cornea can still lose it's transparency by different corneal stromal pathologies (infection ,keratoconus, inflammation ,neurodegeneration and corneal dystrophies).

Recruitment & Eligibility

Status
ENROLLING_BY_INVITATION
Sex
All
Target Recruitment
100
Inclusion Criteria
  • progressive corneal disease with thin corneal thickness
  • corneal low transparenc
  • low visual acuity
Exclusion Criteria
  • active anterior segment pathology
  • previous corneal or anterior segment surgery
  • other infection etc.

Study & Design

Study Type
INTERVENTIONAL
Study Design
SINGLE_GROUP
Arm && Interventions
GroupInterventionDescription
FRESH CORNEAL LENTICULE IMPLANTATIONReLex-smileThe aim in our study is to describe the importance of stroma as criteria of corneal thickness at implanting human fresh corneal lenticule in progressive corneal disease. We have conclude that every biomechanical instability of corneal stroma function(abnormal increase collagen activity,decrease proteinase inhibitors,excessive premature keratocyte apoptosis) describe the role of stroma in corneal thickness.
Primary Outcome Measures
NameTimeMethod
Increase of corneal thickness24 months

Increase of corneal central thickness using human fresh corneal lenticule with stromal stem cells and live keratocytes

Secondary Outcome Measures
NameTimeMethod

Trial Locations

Locations (1)

Eye Hospital Pristina

Pristina, Kosovo

© Copyright 2025. All Rights Reserved by MedPath